Boceprevir for previously untreated patients with chronic hepatitis C Genotype 1 infection: a US-based cost-effectiveness modeling study.
type: Dataset
description: International audience
issued: 2026-05-11T05:32:12.474675
language: en
modified: 2026-05-11T05:32:12.474679
contact point: Organization
  fn: CCSD
keyword: boceprevir
keyword: cost-effectiveness
keyword: economic-evaluation
keyword: hepatitis-c-virus
keyword: infoeu-reposemanticsarticle
keyword: journal-articles
keyword: sdvmhepmilife-sciences-q-biohuman-health-and-pathologyinfectious-diseases
landing page: 1471-2334

Boceprevir for previously untreated patients with chronic hepatitis C Genotype 1 infection: a US-based cost-effectiveness modeling study.
type: Distribution
format: HTML
issued: 2026-05-11T05:32:12.484034
modified: 2026-05-11T05:32:12.464533
access URL: https://inserm.hal.science/inserm-00820362

test_moissonnage_selune
type: Agent